PharmaBoardroom

Against an alluring backdrop, big-name pharma brands are now starting to spend heavily on in-country manufacturing, development and shared service…

Hakhyun Nam, co-founder and CTO at i-SENS, Inc. a developer of glucose sensor devices, reveals his path to running a globally successful medical…

Dr Dan Zhang, CEO of Fountain Medical Development (FMD), details the transformation China’s recent membership at the International Conference on…

Philippe Truelle, President of CDM Lavoisier, highlights the financial impact of the EU’s Falsified Medicines Directive (FMD) on SMEs across Europe…

Ramón Villamarín Valdenebro, general manager of Shionogi Spain, highlights the key steps that needed to be taken to establish the affiliate over the…

Julien Samson, vice president and general manager of GSK Korea explains how GSK’s new global strategy is being delivered within the Korean…

Dr Wang Yinxiang, chairman; and Dr Hu Shaojing, President (R&D); of Jacobio Pharmaceutical; share the exciting story behind Jacobio’s…

Frédéric Collet, president Novartis France and general manager oncology explains the rationale behind Novartis’s consistent investment in…

Javier Alvarado, general manager of Mundipharma Spain, discusses his current priorities and the innovation the company is bringing to the market…

As the 3rd largest pharma region in Asia, Korea's booming pharma industry owes much to its mass of family-run conglomerates known as Chaebol. It…

Carlos Rus Palacios, general secretary of the Alliance of Spanish Private Healthcare (ASPE), the association of private hospitals and private health…

Maria Begona Barragan Garcia, president of GEPAC – the Spanish Group of Patients with Cancer – discusses the necessity of the group and its role…